M. Fujisawa

Spironolactone, but not eplerenone, impairs glucose tolerance in a rat model of metabolic syndrome.

K. Arai, M. Ikeda, T. Sada, 2012, The Journal of veterinary medical science.

Chronotropic Effects of Azelnidipine, a Slow- and Long-acting Dihydropyridine-type Calcium Channel Blocker, in Anesthetized Dogs: A Comparison With Amlodipine

H. Koike, S. Chiba, M. Fujisawa, 2009, Journal of cardiovascular pharmacology.

The Pharmacological Differences in Antianginal Effects of Long-lasting Calcium Channel Blockers: Azelnidipine and Amlodipine

K. Ueno, H. Koike, M. Fujisawa, 2013, Journal of cardiovascular pharmacology.

The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.

K. Ueno, H. Koike, M. Fujisawa, 2012 .

The Pharmacological Differences in Antianginal Effects of Long-lasting Calcium Channel Blockers: Azelnidipine and Amlodipine

K. Ueno, H. Koike, M. Fujisawa, 2012, Journal of cardiovascular pharmacology.